Brain disorders induced by pharmacological blockade of the pentose phosphate pathway.
D000818:Animals; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced* / Q000378:metabolism; D002247:Carbon Isotopes; D002467:Cell Nucleus / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D005956:Glucose-6-Phosphate Isomerase / Q000037:antagonists & inhibitors; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006600:Hexosephosphates / Q000378:metabolism; D008297:Male; D009249:NADP / Q000378:metabolism*; D009536:Niacinamide / Q000378:metabolism / Q000494:pharmacology*; D010243:Paralysis / Q000139:chemically induced; D010428:Pentosephosphates / Q000378:metabolism*; D010734:Phosphogluconate Dehydrogenase / Q000037:antagonists & inhibitors; D012313:RNA / Q000378:metabolism; D051381:Rats
D002247:Carbon Isotopes; D006600:Hexosephosphates; D010428:Pentosephosphates; D009536:Niacinamide; D009249:NADP; D012313:RNA; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005956:Glucose-6-Phosphate Isomerase; D005947:Glucose